Phosphodiesterase 10A inhibitors as a novel therapeutic approach for schizophrenia

Author： Siuciak Judith A   Strick Christine A  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.2, Iss.7, 2007-07, pp. : 1001-1009

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 137-150

Bentham Science Publishers

Access to resources Recommend Favorite

The potential therapeutic use of phosphodiesterase 10 inhibitors

By Kehler Jan   Ritzén Andreas   Greve Daniel Rodriguez  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 2, 2007-02 ,pp. : 147-158

Informa Healthcare

Access to resources Recommend Favorite

Glycine Transporter-1 Inhibitors as Novel Therapeutic Drugs for Schizophrenia

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 3, 2007-09 ,pp. : 177-182

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Targets for Phosphodiesterase 5 Inhibitors: current state-of-the-art on systemic arterial hypertension and atherosclerosis

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 4, 2016-03 ,pp. : 347-364

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Phosphodiesterase (PDE)-4 Inhibitors: A Novel Approach to Treating Memory Deficit?

By Ghavami Afshin  

Drugs in R&D, Vol. 7, Iss. 2, 2006-01 ,pp. : 63-71

Adis International

Access to resources Recommend Favorite